{
    "clinical_study": {
        "@rank": "68810", 
        "arm_group": {
            "arm_group_label": "Natural History", 
            "description": "Assessment of natural history in IBM and CCFDN"
        }, 
        "brief_summary": {
            "textblock": "So far, only limited data is available regarding the natural course in Congenital Cataract\n      Facial Dysmorphism Neuropathy Syndrome (CCFDN) and sporadic and hereditary inclusion body\n      myopathies (IBM). Several criteria and outcome measures have led to contradicting results.\n      The investigators want to retrospectively assess the natural course of the disease in CCFDN\n      and IBM patients according to the data recorded during clinical routine visits."
        }, 
        "brief_title": "Natural History in CCFDN and IBM Syndromes", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Inclusion Body Myositis, Sporadic", 
            "Inclusion Body Myopathy, Autosomal-recessive", 
            "Inclusion Body Myopathy, Autosomal-dominant", 
            "Congenital Cataracts, Facial Dysmorphism, And Neuropathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Cataract", 
                "Muscular Diseases", 
                "Myositis", 
                "Myositis, Inclusion Body", 
                "Contracture", 
                "Ophthalmoplegia"
            ]
        }, 
        "detailed_description": {
            "textblock": "We wanted to assess the natural course in Congenital Cataract Facial Dysmorphism Neuropathy\n      Syndrome (CCFDN) and sporadic and hereditary inclusion body myopathies (IBM) over 10 years\n      to gain new insights in both conditions."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical and/or genetic diagnosis of Congenital Cataract Facial Dysmorphism\n             Neuropathy Syndrome (CCFDN) and sporadic and hereditary inclusion body myopathies\n             (IBM)\n\n        Exclusion Criteria:\n\n          -  Additional neuromuscular diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with CCFDN and IBM"
            }
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01902940", 
            "org_study_id": "CCFDN-IBM-2013", 
            "secondary_id": "CCFDN-IBM-2013"
        }, 
        "intervention": {
            "arm_group_label": "Natural History", 
            "description": "Assessment of natural history in IBM and CCFDN", 
            "intervention_name": "Natural History", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Munich", 
                    "country": "Germany", 
                    "state": "Bavaria", 
                    "zip": "80336"
                }, 
                "name": "Friedrich-Baur-Institut, Ludwig-Maximilians-University of Munich"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Retrospective Cohort Study Assessing the Natural Course in Congenital Cataract Facial Dysmorphism Neuropathy Syndrome (CCFDN) and Sporadic and Hereditary Inclusion Body Myopathies (IBM)", 
        "overall_official": {
            "affiliation": "Friedrich-Baur-Institute, Dept. of Neurology", 
            "last_name": "Maggie C Walter, MD, MA", 
            "role": "Study Chair"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Retrospective", 
            "measure": "Manual Muscle Strength assessed by Medical Research Council (MRC)", 
            "safety_issue": "No", 
            "time_frame": "6-months intervals"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01902940"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ludwig-Maximilians - University of Munich", 
            "investigator_full_name": "Maggie Walter", 
            "investigator_title": "Professor, MD, MA", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ludwig-Maximilians - University of Munich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ludwig-Maximilians - University of Munich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}